Urogen Pharma (UR8) Cash flow

1 Followers

Urogen Pharma Cash Flow

DE:UR8's free cash flow for Q2 2026 was $-33.07M. For the 2026 fiscal year, DE:UR8's free cash flow was decreased by $-65.67M and operating cash flow was $-33.01M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -162.44M	$ -96.77M	$ -76.38M	$ -87.56M	$ -84.89M
Investing Cash Flow	$ 61.56M	$ -20.61M	$ -953.00K	$ 1.06M	$ 4.07M
Financing Cash Flow	$ 39.92M	$ 194.62M	$ 116.93M	$ 97.13M	$ 72.32M
End Cash Position	$ 112.09M	$ 173.06M	$ 95.82M	$ 56.22M	$ 45.59M
Free Cash Flow	$ -162.73M	$ -97.06M	$ -76.57M	$ -87.81M	$ -85.64M

Currency in USD